RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Evansville, IN · +31 more sites
2 recruiting migraine studies with a site in Evansville, IN.
Sponsor: AbbVie
Evansville, IN · +31 more sites
Sponsor: Pfizer
Evansville, IN · +31 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.